No Data
No Data
UBS Downgrades Nanobiotix (NBTX) to a Hold
Express News | Nanobiotix SA : UBS Cuts Target Price to $3.5 From $12
Express News | Nanobiotix SA : UBS Cuts to Neutral From Buy
12 Health Care Stocks Moving In Friday's Pre-Market Session
Nanobiotix to Participate in Multiple Investor Conferences in February and March 2025
Sector Update: Health Care Stocks Rise Premarket Tuesday